Biotech News
-
Valeo Pharma Obtains Public Reimbursement for Enerzair® Breezhaler® and Atectura® Breezhaler® in Ontario, Manitoba and New Brunswick
Atectura and Enerzair also now reimbursed by the Non-Insured Health Benefits (“NIHB”) program of Indigenous Services Canada and Veteran…
-
Voyageur Pharmaceuticals Announces Shareholder Update and Filing of Frances Creek Preliminary Economic Assessment Report
February 24, 2022 (Source) — Voyageur Pharmaceuticals Ltd. (“Voyageur” or the “Company”) (TSXV:VM) (OTC:VYYRF) is pleased to announce the filing of…
-
Valeo Pharma To Host Fourth Quarter And Year-End 2021 Results Conference Call / Webcast
February 21, 2022 (Source) — Valeo Pharma Inc. (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (“Valeo” or the “Company”), a…
-
Zentek Announces Development of Graphene-Wrapped Silicon Anodes
February 18, 2022 (Source) — Zentek Ltd. (“ZEN” or the “Company”) (TSXV:ZEN)(OTC PINK:ZENYF), a Canadian IP development and commercialization…
-
Awakn Life Sciences Drug Discovery Program Files Patent Application for a New Class of Entactogen-Like Molecules
Entactogen NCE Series Enhances the Potential to Treat a Broad Range of Addictions February 17, 2022 (Source) — Awakn…
-
Voyageur Pharmaceuticals Announces Publication of the Jubilee Mountain NI 43-101 Report & Staking of Falcon Claims- Copper Polymetallic Assets
February 16, 2022 (Source) — Voyageur Pharmaceuticals Ltd. (“Voyageur” or the “Company”) (TSXV:VM) (OTC:VYYRF) is pleased to announce the…
-
Awakn Life Sciences’ Professor Celia Morgan Named One of the Most Influential Women in the Psychedelics Industry
Professor Morgan, Awakn’s Head of Ketamine-Assisted Therapy for Addiction, Named One Of The 16 Most Influential Women Shaping…
-
Your Fountain of Youth Trademarked by Hemostemix
February 14, 2022 (Source) — Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) (“Hemostemix” or the “Company”) is pleased…
-
Sixth Wave Provides Corporate Update
February 14, 2022 (Source) — Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) (“Sixth Wave” or the…
-
DIAGNOS Successfully Completes ISO/MDSAP Audit
February 10, 2022 (Source) — Diagnos Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader…
